億晶光電(600537.SH):常州億晶已收到公司和金沙科技各7億元增資款
格隆匯 1 月 15日丨億晶光電(600537.SH)公佈,2021年1月15日,常州億晶新開立的增資專用賬户收到了由金沙科技支付的7億元人民幣增資款,金沙科技完成了增資協議約定的應由其支付的第一期增資款。
截至公吿日,常州億晶已經收到上市公司和金沙科技各7億元人民幣增資款,合計14億元人民幣。
根據增資協議約定,上市公司和金沙科技須在2021年6月30日前分別向常州億晶支付5億元人民幣增資款,公司將持續根據增資事項的進展,並及時履行相應的信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.